Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Adam J. Olszewski Michele Bibas Jorge Castillo Jose-Tomás Navarro John L Reagan |
| Publication date | March 12, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |